Your browser doesn't support javascript.
loading
LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation.
Joller, Nicole; Anderson, Ana C; Kuchroo, Vijay K.
Afiliação
  • Joller N; Department of Quantitative Biomedicine, University of Zurich, 8057 Zurich, Switzerland.
  • Anderson AC; Gene Lay Institute of Immunology and Inflammation, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Kuchroo VK; Gene Lay Institute of Immunology and Inflammation, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA. Electronic address: vkuchroo@bwh.harvard.edu.
Immunity ; 57(2): 206-222, 2024 Feb 13.
Article em En | MEDLINE | ID: mdl-38354701
ABSTRACT
LAG-3, TIM-3, and TIGIT comprise the next generation of immune checkpoint receptors being harnessed in the clinic. Although initially studied for their roles in restraining T cell responses, intense investigation over the last several years has started to pinpoint the unique functions of these molecules in other immune cell types. Understanding the distinct processes that these receptors regulate across immune cells and tissues will inform the clinical development and application of therapies that either antagonize or agonize these receptors, as well as the profile of potential tissue toxicity associated with their targeting. Here, we discuss the distinct functions of LAG-3, TIM-3, and TIGIT, including their contributions to the regulation of immune cells beyond T cells, their roles in disease, and the implications for their targeting in the clinic.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Receptor Celular 2 do Vírus da Hepatite A Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Receptor Celular 2 do Vírus da Hepatite A Idioma: En Ano de publicação: 2024 Tipo de documento: Article